Cleveland Clinic | 12th Annual Obesity Summit
Avatar

Management of Hypertension and Hyperlipidemia in Type 2 Diabetes

By Cleveland Clinic | 12th Annual Obesity Summit FEATURING Steven Nissen
December 3, 2017
2 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Houston Methodist DeBakey Heart and Vascular Center

5th Annual Cardiology for the Non-Cardiologist

Sat, May 22, 2021
National Lipid Association

Summer of Lipids 2021

Fri, Jun 4, 2021
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

16:57
William White

Ambulatory Blood Pressure Monitoring

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition

Feat. R. DeFronzo
28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty Acids…

Feat. R. Mason
18:25
ARCH Advanced Revascularization Symposium

Hypertension 2016: Guidelines and Updates

42:25
Piedmont Heart Institute

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How To Trea…

Feat. A. Klein
12:52
Scripps Health: 2020 Updates in Diabetes Management

Update on SGLT2i in Diabetic Kidney Disease: How Effective Are Canaglifloz…

Feat. K. Harper
42:27
Physicians Committee for Responsible Medicine

Hypertension Management & Nutrition: What Are the Key Nutrients for Blood …

Feat. V. Rahman
10:03
Scripps Health: 2019 Updates in Diabetes Management

Multi-specialty Approach to Diabetes, Discussion with Nephrology

Feat. K. Harper
39:29
37th Annual Advances in Heart Disease

Contemporary Approach for Managing PAD: What Are the Guideline Recommended…

Feat. M. Creager, B. An Phan
28:22
Richard Auchus

Primary Aldosteronism and Implications for Primary Hypertension

10:41
Houston Methodist DeBakey Heart and Vascular Center

2020 High Blood Pressure Guidelines: When Is BP Too High?

Feat. A. Marie Navar
18:02
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Novelties in Lipid Lowering Therapies: Can Statin Therapy Reduce Residual …

Feat. P. Taub
13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

35:57
37th Annual Advances in Heart Disease

Updates in Preoperative Evaluation in Patients Undergoing Non-cardiac Surg…

Feat. R. Eshima Mckay
07:35
ASPC 2020 Virtual Summit on CVD Prevention

Continuity of Care for Patients With/At High Risk for CVD During COVID-19 …

Feat. A. Khera
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

13:57
American Heart & Vascular Institute

Update on Lipid Management for ASCVD Prevention: What Is New in the Choles…

Feat. E. Brinton
29:14
Michael Ozner

The Role of Omega-3 Fatty Acids for the Treatment and Prevention of Cardio…

28:09
ASPC 2019 Congress on CVD Prevention

LDL-C lowering and the Brain: Differentiating Fact from Fiction

Feat. P. Toth